Vor Biopharma Inc. (VOR) stock

VORNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 5/30

$19.32−0.77 (-3.83%)

Close on Nov 12, 2026Market cap $1.19BP/E –Yield –

Vor Biopharma statistics

55 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $1.19B; $280.48M
Enterprise Value: $705.31M; $148.62M

Share statisticsIndustry

Shares Outstanding: 61M; 58M
Shares Change (QoQ): 12.8%; 0.51%
Shares Held by Institutions: 80.3%; 56.4%

Short sellingIndustry

Short Interest: 8M; –
Short Interest Change: 0.79%; -0.76%
Short % of Shares Outstanding: 12.2%; 6.30%
Days to Cover: 9.88; 5.13

Stock price statisticsIndustry

52-Week High: $26.00; –
52-Week Low: $6.50; –
20-Day Moving Average: $19.35; –
50-Day Moving Average: $20.09; –
200-Day Moving Average: $17.50; –
Average True Range (14): $1.22; –
Price Change (1 Week): 3.54%; 1.51%
Price Change (1 Month): 3.04%; -2.35%
Price Change (3 Months): -16.1%; -21.1%
Price Change (6 Months): 28.2%; -22.6%
Price Change (YTD): 47.7%; -22.6%
Price Change (1 Year): 96.3%; -20.7%
Price Change (3 Years): -46.0%; -27.4%
Price Change (5 Years): -94.6%; -77.3%
Average Volume (10 Days): 660,275; –
Average Volume (20 Days): 717,204; –
Average Volume (90 Days): 931,468; –
Relative Volume: 0.84; 0.79
Relative Strength Index (14): 48.2; 44.7
Volatility (1 Year): 93.4%; 80.4%
Beta (5 Years): 2.08; 1.07

Returns on capitalIndustry

Return on Assets (ROA): 402.6%; -40.6%
Return on Capital Employed (ROCE): -38.6%; -38.0%

Financial positionIndustry

Current Ratio: 13.50; 3.30
Quick Ratio: 13.25; 2.42

EfficiencyIndustry

Profits Per Employee: $17.81M; -$683.67K
Employee Count: 76; 75
WACC: 15.4%; 10.1%

Income statement (TTM)Industry

Operating Income: -$177.42M; -$20.99M
Net Income: $1.35B; -$21.61M
EBITDA: -$177.42M; -$16.85M

Balance sheetIndustry

Cash & Short-Term Investments: $481.60M; $67.63M
Net Cash (Debt): $481.60M; $17.46M
Net Cash Per Share: $7.84; $0.72
Equity (Book Value): -$137.17M; $53.27M
Book Value Per Share: -$2.23; $1.50
Tangible Book Value: -$137.17M; $26.82M
Working Capital: $454.18M; $79.47M

Cash flow (TTM)Industry

Operating Cash Flow: -$119.17M; -$12.27M
Capital Expenditures: -$507.00K; -$944.00K
Free Cash Flow: -$119.68M; -$18.20M
FCF Per Share: -$1.95; -$0.42

Dividends and yieldsIndustry

Earnings Yield: 114.1%; -20.8%
FCF Yield: -10.1%; -9.58%

Scores and fair valueIndustry

Altman Z-Score: -3.25; 0.30
Piotroski F-Score: 3; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	VOR	S&P 500	Difference	VOR per year	S&P 500 per year
1 month	-2.4%	-2.7%	+0.3 pts
3 months	-13.5%	-1.7%	−11.8 pts
Year to date	+47.7%	+11.9%	+35.8 pts
1 year	+92.0%	+12.0%	+80.1 pts
3 years	-45.1%	+78.2%	−123.3 pts	-18.1%	+21.2%
5 years	-94.6%	+73.2%	−167.8 pts	-44.1%	+11.6%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

8M VOR shares were sold short on Oct 30, 2026, up 0.8% from the previous report. At recent volumes it would take 9.9 days to buy them back. Over the last 20 sessions, 50.4% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	7,504,425	+0.8%	759,510	9.9
Oct 15, 2026	7,445,537	-4.7%	830,455	9.0
Sep 30, 2026	7,814,764	-1.1%	1,801,970	4.3
Sep 15, 2026	7,904,520	+3.1%	710,546	11.1
Aug 31, 2026	7,666,676	+4.3%	739,511	10.4
Aug 14, 2026	7,350,765	+1.4%	747,112	9.8
Jul 31, 2026	7,251,707	-0.5%	871,822	8.3
Jul 15, 2026	7,289,116	-5.9%	1,667,524	4.4
Jun 30, 2026	7,743,558	+30.1%	2,057,942	3.8
Jun 15, 2026	5,951,225	+23.5%	834,099	7.1
May 29, 2026	4,818,351	+4.9%	804,527	6.0
May 15, 2026	4,595,199	-7.3%	873,880	5.3

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?